http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011275928-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5607
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
filingDate 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f75a81b88d1ff16af7fdc839234d5f1
publicationDate 2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011275928-A1
titleOfInvention Blood signal suppressed enhanced magnetic resonance imaging
abstract Methods for achieving suppression of blood pool signal to image contrast-enhanced organs and vascular walls using magnetic resonance (MR) imaging technology. After administration of e.g., an intravenous contrast agent, an RF pulse sequence is applied that includes a preparatory section designed to modify signal from organ tissue differently than blood pool signal, followed by an inversion RF pulse. MR signals are then allowed to evolve during a wait time that is sufficiently long to permit tissue species with dissimilar T1 relaxation times to separate in signal yet short enough so that blood signal has greater negative magnetization than other tissues of interest. MRI data is then acquired with phase sensitive reconstruction so that blood pool signal is suppressed compared with the tissues of interest.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10156625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11573281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102764126-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017315198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014103929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10557906-B2
priorityDate 2010-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011260725-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005215883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003069496-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7941204-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009005673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010106007-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128350320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226588220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129312736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129633601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29919956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135887726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226453121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127472126

Total number of triples: 41.